Application 203148

Type
ANDA
Sponsor
MACLEODS PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 1.5MG BASENoNo
002RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 3MG BASENoNo
003RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 4.5MG BASENoNo
004RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 6MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
33342-089RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-089RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-089RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent
33342-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATEMacleods Pharmaceuticals LimitedANDACurrent